Enhanced care by generalists for functional somatic symptoms and disorders in primary care

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 10, 2013, Pages

  Rosendal, Marianne ^a   Blankenstein, Annette H ^b   Morriss, Richard ^c   Fink, Per ^d   Sharpe, Michael ^e   Burton, Christopher ^f  

^a AARHUS UNIVERSITY   (Denmark)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e WARNEFORD HOSPITAL   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; CLINICAL EFFECTIVENESS; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; FUNCTIONAL SOMATIC SYMPTOM; FUNCTIONAL STATUS; HEALTH CARE UTILIZATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MEDICAL LEAVE; MENTAL DISEASE ASSESSMENT; MENTAL HEALTH; PATIENT HEALTH QUESTIONNAIRE 15; PATIENT SATISFACTION; PATIENT WORRY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHORT FORM 12; SHORT FORM 36; SHORT FORM 8; SOMATIC SYMPTOM INDEX; SYMPTOM CHECKLIST; SYSTEMATIC REVIEW; ADULT; GENERAL PRACTICE; META ANALYSIS; METHODOLOGY; PROCEDURES; PSYCHOPHYSIOLOGIC DISORDERS;

ADULT; GENERAL PRACTICE; HUMANS; PSYCHOPHYSIOLOGIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84899610070     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008142.pub2     Document Type: Review

References (156)

1. Blankenstein AH. Somatising patients in general practice. Reattribution, a promising approach (PhD thesis). Amsterdam: Vrije Universiteit, 2001. [: http://dspace.ubvu.vu.nl/handle/1871/11723?show=full (accessed 30 July 2013)]
2. Larisch A, Schweickhardt A, Wirsching M, Fritzsche K. Psychosocial interventions for somatizing patients by the general practitioner: a randomized controlled trial. Journal of Psychosomatic Research 2004;57(6):507-14.
3. Schweickhardt A, Larisch A, Fritzsche K. Differentiation of somatizing patients in primary care: why the effects of treatment are always moderate. Journal of Nervous and Mental Diseases 2005;193(12):813-9.
4. Dowrick C, Gask L, Hughes JG, Charles-Jones H, Hogg JA, Peters S, et al.General practitioners' views on reattribution for patients with medically unexplained symptoms: a questionnaire and qualitative study. BMC Family Practice 2008;9:46.
5. Morriss R. Specific psychosocial interventions for somatizing patients by the general practitioner: a randomised controlled trial.[comment]. Journal of Psychosomatic Research 2004;57(6):515-6.
6. Morriss R, Dowrick C, Salmon P, Peters S, Dunn G, Rogers A, Gask L. "Reattribution for medically unexplained symptoms": Authors' reply. British Journal of Psychiatry 2008;192(4):315.
7. Morriss R, Dowrick C, Salmon P, Peters S, Dunn G, Rogers A, et al.Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. British Journal of Psychiatry 2007;191:536-42.
8. Morriss R, Dowrick C, Salmon P, Peters S, Rogers A, Dunn G, et al.Turning theory into practice: rationale, feasibility and external validity of an exploratory randomized controlled trial of training family practitioners in reattribution to manage patients with medically unexplained symptoms (the MUST). General Hospital Psychiatry 2006;28(4):343-51.
9. Morriss R, Gask L, Dowrick C, Dunn G, Peters S, Ring A, et al.Randomized trial of reattribution on psychosocial talk between doctors and patients with medically unexplained symptoms. Psychol.Med. 2010;40(2):325-33.
10. van Ravesteijn Hiske J, Lucassen PL, Olde Hartman TC. Reattribution for medically unexplained symptoms. British Journal of Psychiatry 2008;192(4):314-5.
11. Rief W, Martin A, Rauh E, Zech T, Bender A. Evaluation of general practitioners' training: how to manage patients with unexplained physical symptoms. Psychosomatics 2006;47(4):307-11.
12. Rosendal M, Bro F, Fink P, Christensen KS, Olesen F. Diagnosis of somatisation: effect of an educational intervention in a cluster randomised controlled trial. The British Journal of General Practice 2003;53:917-22.
13. Rosendal M, Bro F, Sokolowski I, Fink P, Toft T, Olesen F. A randomised controlled trial of brief training in assessment and treatment of somatisation: Effects on general practitioners' attitudes. Family Practice 2005; Vol. 22:419-27.
14. Rosendal M, Olesen F, Fink P, Toft T, Sokolowski I, Bro F. A randomized controlled trial of brief training in the assessment and treatment of somatization in primary care: effects on patient outcome. General Hospital Psychiatry 2007;29(4):364-73.
15. Christensen KS, Toft T, Frostholm L, Ornbol E, Fink P, Olesen F. Screening for common mental disorders: who will benefit? Results from a randomised clinical trial. Family Practice 2005;22(4):428-34.
16. Christensen KS, Toft T, Frostholm L, Ornbol E, Fink P, Olesen F. The FIP Study: A randomised, controlled trial of screening and recognition of psychiatric disorders. The British Journal of General Practice 2003;53(495):758-63.
17. Fink P, Rosendal M, Toft T. Assessment and treatment of functional disorders in general practice: the extended reattribution and management model - an advanced educational program for nonpsychiatric doctors. Psychosomatics 2002;43(0033-3182, 2):93-131.
18. Frostholm L, Fink P, Oernboel E, Christensen KS, Toft T, Olesen F, et al.The uncertain consultation and patient satisfaction: the impact of patients' illness perceptions and a randomized controlled trial on the training of physicians' communication skills. Psychosomatic Medicine 2005;67(6):897-905.
19. Frostholm L, Fink P, Oernboel E, Christensen KS, Toft T, Olesen F, et al.The uncertain consultation and patient satisfaction: the impact of patients' illness perceptions and a randomized controlled trial on the training of physicians' communication skills. Psychosomatic Medicine 2005;67(6):897-905.
20. Hansen HS, Rosendal M, Oernboel E, Fink P. Are medically unexplained symptoms and functional disorders predictive for the illness course? A two-year follow-up on patients' health and health care utilisation. Journal of Psychosomatic Research 2011;71(1):38-44.
21. Toft T, Fink P, Oernboel E, Christensen KS, Frostholm L, Olesen F. Mental disorders in primary care: prevalence and co-morbidity among disorders. Results from the Functional Illness in Primary care (FIP) study. Psychological Medicine 2005;35(8):1175-84.
22. Toft T, Rosendal M, Ornbol E, Olesen F, Frostholm L, Fink, P. Training general practitioners in the treatment of functional somatic symptoms: effects on patient health in a cluster-randomised controlled trial (the Functional Illness in Primary Care study). Psychotherapy and Psychosomatics 2010;79(4):227-37.
23. Whitehead L, Campion P. Can general practitioners manage Chronic Fatigue Syndrome? A controlled trial. Journal of Chronic Fatigue Syndrome 2002;10(1):55-64.
24. Aiarzaguena JM, Grandes G, Gaminde I, Salazar A, Sanchez A, Arino J, et al.A randomized controlled clinical trial of a psychosocial and communication intervention carried out by GPs for patients with medically unexplained symptoms. Psychological Medicine 2007;37(2):283-94.
25. Alamo MM, Moral RR, Perula de Torres LA. Evaluation of a patient-centred approach in generalized musculoskeletal chronic pain/fibromyalgia patients in primary care. Patient Education and Counseling 2002;48(1):23-31.
26. Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Archives of Internal Medicine 2006;166(14):1512-8.
27. Bakker IMT. A cluster-randomised trial evaluating an intervention for patients with stress-related mental disorders and sick leave in primary care. PLoS Clinical Trials 2007;2(6):e26.
28. Barsky AJ, Ahern DK, Barsky Arthur J, Ahern David K. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA 2004;291(12):1464-70.
29. Bernal I, Cercos A, Fuste I, Vallverdu R, Urbieta Solana R, Montesinos Molina I. Relaxation therapy in patients with anxiety and somatoform disorders in primary-care [Tratamiento de relajacion en pacientes con trastornos de ansiedad y somatoformes en atencion primaria]. Atencion Primaria 1995;15(8):499-504.
30. Escobar JI, Gara M, Alex I, Allen L, Diaz-Martinez A, Warman M. Treatment of patients presenting with unexplained physical symptoms in primary care. Neuropsychopharmacology 2004;29 Suppl 1:S101.
31. Escobar JI, Gara MA, Diaz-Martinez AM, Interian A, Warman M, Allen LA, et al.Effectiveness of a time-limited cognitive behavior therapy type intervention among primary care patients with medically unexplained symptoms. Annals of Family Medicine 2007;5(4):328-35.
32. Huibers MJ, Beurskens AJ, van Schayck CP, Bazelmans E, Metsemakers JF, Knottnerus JA, et al.Efficacy of cognitive-behavioural therapy by general practitioners for unexplained fatigue among employees: Randomised controlled trial. British Journal of Psychiatry 2004;184:240-6.
33. Huibers MJ, Bleijenberg G, Van Amelsvoort LGPM, Beurskens AJ, Van Schayck CP, Bazelmans E, et al.Predictors of outcome in fatigued employees on sick leave: Results from a randomised trial. Journal of Psychosomatic Research 2004;57(5):443-9.
34. Huibers MJ, Leone SS, van Amelsvoort LG, Kant I, Knottnerus JA. Associations of fatigue and depression among fatigued employees over time: a 4-year follow-up study. Journal of Psychosomatic Research 2007;63(2):137-42.
35. Leone SS, Huibers MJ, Kant I, van Amelsvoort LG, Van Schayck CP, Bleijenberg G, et al.Long-term efficacy of cognitive-behavioral therapy by general practitioners for fatigue: a 4-year follow-up study. Journal of Psychosomatic Research 2006;61(5):601-7.
36. Jellema P, van der RN, van der Windt DA, van Tulder MW, van der Horst HE, Stalman WA, et al.Low back pain in general practice: cost-effectiveness of a minimal psychosocial intervention versus usual care. European Spine Journal 2007;16(11):1812-21.
37. Jellema P, van der Windt DA, van der Horst HE, Twisk JW, Stalman WA, Bouter LM, et al.Should treatment of (sub)acute low back pain be aimed at psychosocial prognostic factors? Cluster randomised clinical trial in general practice. BMJ 2005;331(7508):84.
38. Kennedy T, Jones R, Darnley S, Seed P, Wessely S, Chalder T, et al.Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ 2005;331(7514):435.
39. Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, et al.Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial. Health Technology Assessment (Winchester, England) 2001;10(19):1-67.
40. McCrone P, Knapp M, Kennedy T, Seed P, Jones R, Darnley S, et al.Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2008;20(4):255-63.
41. Klapow JC, Schmidt SM, Taylor LA, Roller P, Li Q, Calhoun JW, et al.Symptom management in older primary care patients: feasibility of an experimental, written self-disclosure protocol. Annals of Internal Medicine 2001;134(9 Pt 2):905-11.
42. Leonhardt C, Keller S, Chenot JF, Luckmann J, Basler HD, Wegscheider K, et al.TTM-based motivational counselling does not increase physical activity of low back pain patients in a primary care setting--A cluster-randomized controlled trial. Patient Education and Counseling 2008;70(1):50-60.
43. Lidbeck J. Group therapy for somatization disorders in primary care: Maintenance of treatment goals of short cognitive-behavioural treatment one-and-a-half-year follow-up. Acta Psychiatrica Scandinavica 2003;107(6):01.
44. Lidbeck J, Lidbeck J. Group therapy for somatization disorders in general practice: effectiveness of a short cognitive-behavioural treatment model. Acta Psychiatrica Scandinavica 1997;96(1):14-24.
45. Lofvander M. Cognitive-behavioural treatment of chronic pain in primary care: a three-year follow-up. European Journal of General Practice 2002;8:151-8.
46. Magallon R, Gili M, Moreno S, Bauza N, Garcia-Campayo J, Roca M, et al.Cognitive-behaviour therapy for patients with Abridged Somatization Disorder (SSI 4, 6) in primary care: a randomized, controlled study [trial protocol]. BMC Psychiatry 2008; Vol. 8:47.
47. Margalit AP, El Ad A, Margalit APA, El Ad A. Costly patients with unexplained medical symptoms: a high-risk population. Patient Education and Counseling 2008;70(2):173-8.
48. Martin A, Rauh E, Fichter M, Rief W, Martin A, Rauh E, et al.A one-session treatment for patients suffering from medically unexplained symptoms in primary care: a randomized clinical trial. Psychosomatics 2007;48(4):294-303.
49. McLeod CC, Budd MA, McClelland DC, McLeod CC, Budd MA, McClelland DC. Treatment of somatization in primary care. General Hospital Psychiatry 1997;19(4):251-8.
50. Pols RG, Battersby MW, Pols RG, Battersby MW. Coordinated care in the management of patients with unexplained physical symptoms: depression is a key issue. Medical Journal of Australia 2008;188(12 Suppl):S133-7.
51. Chisholm D, Godfrey E, Ridsdale L, Chalder T, King M, Seed P, et al.Chronic fatigue in general practice: Economic evaluation of counselling versus cognitive behaviour therapy. The British Journal of General Practice 2001;51(462):15-8.
52. Ridsdale L, Darbishire L, Seed PT. Is graded exercise better than cognitive behaviour therapy for fatigue? A UK randomized trial in primary care. Psychological Medicine 2004;34(1):37-49.
53. Ridsdale L, Godfrey E, Chalder T, Seed P, King M, Wallace P, et al.Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. The British Journal of General Practice 2001;51(462):19-24.
54. Schade N, Torres P, Beyebach M. Cost-efficiency of a brief family intervention for somatoform patients in primary care. Families, Systems, & Health 2011;29(3):197-205.
55. Schaefert R, Kaufmann C, Bölter R, Faber R, Wild B, Szecseny J, et al.Somatoforme Syndromes in general practice [Somatoforme Syndrome in der Hausartzpraxis]. Psychotherapeut 2011;56:315-24.
56. Schilte AF, Portegijs PJ, Blankenstein AH, Der Horst HE, Latour MB, van Eijk JT, et al.Randomised controlled trial of disclosure of emotionally important events in somatisation in primary care. BMJ 2001;323(7304):86.
57. Luo Z, Goddeeris J, Gardiner JC, Smith RC. Costs of an intervention for primary care patients with medically unexplained symptoms: a randomized controlled trial. Psychiatric Services 2007;58(8):1079-86.
58. Lyles JS, Hodges A, Collins C, Lein C, Given CW, Given B, et al.Using nurse practitioners to implement an intervention in primary care for high-utilizing patients with medically unexplained symptoms. General Hospital Psychiatry 2003;25(2):63-73.
59. Smith RC, Korban E, Kanj M, Haddad R, Lyles JS, Lein C, et al.A method for rating charts to identify and classify patients with medically unexplained symptoms. Psychotherapy and Psychosomatics 2004;73(1):36-42.
60. Smith RC, Lein C, Collins C, Lyles JS, Given B, Dwamena FC, et al.Treating patients with medically unexplained symptoms in primary care. Journal of General Internal Medicine 2003;18(6):478-89.
61. Smith RC, Lyles JS, Gardiner JC, Sirbu C, Hodges A, Collins C, et al.Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. Journal of General Internal Medicine 2006;21(7):671-7.
62. Smith RC, Gardiner JC, Luo Z, Schooley S, Lamerato L, Rost K. Primary care physicians treat somatization. Journal of General Internal Medicine 2009;24(7):829-32.
63. Sumathipala A, Hewege S, Hanwella R, Mann AH. Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: a feasibility study in Sri Lanka. Psychological Medicine 2000;30(4):747-57.
64. Sumathipala A, Siribaddana S, Abeysingha MR, De Silva P, Dewey M, Prince M, et al.Cognitive-behavioural therapy v. structured care for medically unexplained symptoms: randomised controlled trial. British Journal of Psychiatry 2008;193(1):51-9.
65. Van Bokhoven L, Bindels P, Dinant G, Grol R, Koch H, Van Der Weijden T. The diagnostic approach of early stage unexplained complaints [abstract]. Journal of Psychosomatic Research [abstracts of the 15th Annual Meeting of the European Association for Consultation-Liaison Psychiatry and Psychosomatics, EACLPP and 29th European Conference on Psychosomatic Research, ECPR; 2012 Jun 27-30; Aarhus Denmark] 2012;72(6):505.
66. van Bokhoven MA, Koch H, van der WT, Grol RP, Kester AD, Rinkens PE, et al.Influence of watchful waiting on satisfaction and anxiety among patients seeking care for unexplained complaints. Annals of Family Medicine 2009;7(2):112-20.
67. van Bokhoven MA, Koch H, van der Weijden T, Weekers Muyres AH, Bindels PJ, Grol RP. The effect of watchful waiting compared to immediate test ordering instructions on general practitioners' blood test ordering behaviour for patients with unexplained complaints; a randomized clinical trial. Implementation Science 2012;7:29.
68. van der Horst HE. Irritable Bowel Syndrome in General Practice, how effective is patient education and counselling?. Amsterdam: PhD Thesis, Vrije Universiteit Amsterdam, 1997.
69. Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?. International Journal of Epidemiology 2006;35(2):468-76.
70. Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosomatic Medicine 2002;64(6):939-50.
71. Andrews G, Peters L, Guzman AM, Bird K. A comparison of two structured diagnostic interviews: CIDI and SCAN. The Australian and New Zealand Journal of Psychiatry 1995;29(1):124-32.
72. Archer J, Bower P, Gilbody S, Lovell K, Richards D, Gask L, Dickens C, Coventry P. Collaborative care for depression and anxiety problems. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD006525.pub2]
73. Barsky AJ, Fama JM, Bailey ED, Ahern DK. A prospective 4- to 5-year study of DSM-III-R hypochondriasis. Archives of General Psychiatry 1998;55(8):737-44.
74. Barsky AJ, Ettner SL, Horsky J, Bates DW. Resource utilization of patients with hypochondriacal health anxiety and somatization. Medical Care 2001;39(7):705-15.
75. Boerma WG, Verhaak PF. The general practitioner as the first contacted health professional by patients with psychosocial problems: a European study. Psychological Medicine 1999;29(3):689-96.
76. Bower P, Knowles S, Coventry PA, Rowland N. Counselling for mental health and psychosocial problems in primary care. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI: 10.1002/14651858.CD001025.pub3]
77. Brody DS, Lerman CE, Wolfson HG, Caputo GC. Improvement in physicians' counseling of patients with mental health problems. Archives of Internal Medicine 1990;150(5):993-8.
78. Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Medical Research Methodology 2006;8(6):54.
79. Burbaum C, Stresing AM, Fritzsche K, Auer P, Wirsching M, Lucius-Hoene G. Medically unexplained symptoms as a threat to patients' identity? A conversation analysis of patients' reactions to psychosomatic attributions. Patient Education and Counseling 2010;79(2):207-17.
80. Burton C, Weller D, Marsden W, Worth A, Sharpe M. A primary care Symptoms Clinic for patients with medically unexplained symptoms: pilot randomised trial. BMJ Open 2012;2:e000513. [DOI: 10.1136/bmjopen-2011-000513]
81. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP. Development of a fatigue scale. Journal of Psychosomatic Research 1993;37(2):147-53.
82. Chew-Graham C, Brooks J, Wearden A, Dowrick C, Peters S. Factors influencing engagement of patients in a novel intervention for CFS/ME: a qualitative study. Primary Health Care Research and Development 2011;12(2):112-22.
83. Craig TK, Boardman AP, Mills K, Daly-Jones O, Drake H. The South London Somatisation Study. I: Longitudinal course and the influence of early life experiences. British Journal of Psychiatry 1993;163:579-88.
84. Creed F, Guthrie E, Fink P, Henningsen P, Rief W, Sharpe M, et al.Is there a better term than "medically unexplained symptoms"?. Journal of Psychosomatic Research 2010;68(1):5-8.
85. de Waal MW, Arnold IA, Eekhof JA, van Hemert AM. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. British Journal of Psychiatry 2004;184:470-6.
86. Deary IJ. A taxonomy of medically unexplained symptoms. Journal of Psychosomatic Research 1999;47(1):51-9.
87. Derogatis LR, Cleary PA. Confirmation of the dimensional structure of the SCL-90: A study in construct validation. Journal of Clinical Psychology 1977;33(4):981-9.
88. Dowrick CF, Ring A, Humphris GM, Salmon P. Normalisation of unexplained symptoms by general practitioners: a functional typology. The British Journal of General Practice 2004;54(500):165-70.
89. Eaton WW, Neufeld K, Chen LS, Cai G. A comparison of self-report and clinical diagnostic interviews for depression: diagnostic interview schedule and schedules for clinical assessment in neuropsychiatry in the Baltimore epidemiologic catchment area follow-up. Archives of General Psychiatry 2000;57(3):217-22.
90. Escobar JI, Rubio-Stipec M, Canino G, Karno M. Somatic symptom index (SSI): a new and abridged somatization construct. Prevalence and epidemiological correlates in two large community samples. The Journal of Nervous and Mental Disease 1989;177(3):140-6.
91. Fink P, Ewald H, Jensen J, Engberg M, Holm M, Munk-Jorgensen P. Screening for somatization and hypochondriasis in primary care and neurological inpatients. A 7-item scale for hypochondriasis and somatization. Journal of Psychosomatic Research 1999;46(3):261-73.
92. Fink P, Sorensen L, Engberg M, Holm M, Munk-Jorgensen P. Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition. Psychosomatics 1999;40(4):330-8.
93. Fink P, Toft T, Hansen MS, Ornbol E, Olesen F. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosomatic Medicine 2007;69(1):30-9.
94. Francis A, Pincus HA, First MB. DSM-IV: Diagnostic and statistical manual of mental disorders. 4th Edition. Washington DC: American Psychiatric Association, 1994.
95. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al.Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology 1998;51(11):1171-8.
96. Gask L, Dowrick C, Salmon P, Peters S, Morriss R. Reattribution reconsidered: narrative review and reflections on an educational intervention for medically unexplained symptoms in primary care settings. Journal of Psychosomatic Research 2011;71(5):325-34.
97. Goldberg DP, Williams P. A user's guide to the General Health Questionnaire. NFER-Nelson, 1988.
98. Goldberg D, Gask L, O'Dowd T. The treatment of somatization: teaching techniques of reattribution. Journal of Psychosomatic Research 1989;33(6):689-95.
99. Graugaard PK, Eide H, Finset A. Interaction analysis of physician-patient communication: the influence of trait anxiety on communication and outcome. Patient Education and Counseling 2003;49(2):149-56.
100. Grol R, Wensing M, Mainz J, Ferreira P, Hearnshaw H, Hjortdahl P, et al.Patients' priorities with respect to general practice care: an international comparison. European Task Force on Patient Evaluations of General Practice (EUROPEP). Family Practice 1999;16(1):4-11.
101. Gureje O, Simon GE, Ustun TB, Goldberg DP. Somatization in cross-cultural perspective: a World Health Organization study in primary care. American Journal of Psychiatry 1997;154(7):989-95.
102. Gureje O, Simon GE. The natural history of somatization in primary care. Psychological Medicine 1999;29(3):669-76.
103. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet 2007;369(9565):946-55.
104. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Available from www.cochrane-handbook.org. The Cochrane Collaboration, March 2011.
105. Hill JC, Whitehurst DG, Lewis M, Bryan S, Dunn KM, Foster NE, et al.Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet 2011;378(9802):1560-71.
106. Hoedeman R, Blankenstein AH, van der Feltz-Cornelis CM, Krol B, Stewart R, Groothoff JW. Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD006524.pub2]
107. Hotopf M, Mayou R, Wadsworth M, Wessely S. Temporal relationships between physical symptoms and psychiatric disorder. Results from a national birth cohort. British Journal of Psychiatry 1998;173:255-61.
108. Huibers MJH, Beurskens AJHM, Bleijenberg G, Schayck CP van. Psychosocial interventions by general practitioners. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003494.pub2]
109. Kaaya S, Goldberg D, Gask L. Management of somatic presentations of psychiatric illness in general medical settings: evaluation of a new training course for general practitioners. Medical Education 1992;26(2):138-44.
110. Katon W, Lin E, Von Korff M, Russo J, Lipscomb P, Bush T. Somatization: a spectrum of severity. American Journal of Psychiatry 1991;148(1):34-40.
111. Katon W, Von Korff M, Lin E, Bush T, Russo J, Lipscomb P, et al.A randomized trial of psychiatric consultation with distressed high utilizers. General Hospital Psychiatry 1992;14(2):86-98.
112. Kirmayer LJ, Robbins JM. Three forms of somatization in primary care: prevalence, co-occurrence, and sociodemographic characteristics. The Journal of Nervous and Mental Disease 1991;179(11):647-55.
113. Kisely S, Campbell LA, Skerritt P. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD004101.pub2]
114. Kleinstauber M, Witthoft M, Hiller W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clinical Psychology Review 2011;31(1):146-60.
115. Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. American Journal of Medicine 1989;86(3):262-6.
116. Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruy FV III, et al.Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Archives of Family Medicine 1994;3(9):774-9.
117. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychotherapy and Psychosomatics 2000;69(4):205-15.
118. Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic Medicine 2002;64(2):258-66.
119. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosomatic Medicine 2007; Vol. 69:881-8.
120. Lieb R, Zimmermann P, Friis RH, Hofler M, Tholen S, Wittchen HU. The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective-longitudinal community study. European Psychiatry 2002;17(6):321-31.
121. Lin EH, Katon W, Von Korff M, Bush T, Lipscomb P, Russo J, et al.Frustrating patients: physician and patient perspectives among distressed high users of medical services. Journal of General Internal Medicine 1991;6(3):241-6.
122. Morriss R, Gask L, Ronalds C, Downes-Grainger E, Thompson H, Leese B, et al.Cost-effectiveness of a new treatment for somatized mental disorder taught to GPs. Family Practice 1998;15(2):119-25.
123. Morriss R, Gask L, Ronalds C, Downes-Grainger E, Thompson H, Goldberg D. Clinical and patient satisfaction outcomes of a new treatment for somatized mental disorder taught to general practitioners. The British Journal of General Practice 1999;49:263-7.
124. Morriss RK, Gask L. Treatment of patients with somatized mental disorder: effects of reattribution training on outcomes under the direct control of the family doctor. Psychosomatics 2002;43(5):394-9.
125. Olde Hartman TC, Borghuis MS, Lucassen PL, van de Laar FA, Speckens AE, van Weel C. Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. Journal of Psychosomatic Research 2009;66(5):363-77.
126. Peters S, Rogers A, Salmon P, Gask L, Dowrick C, Towey M, et al.What do patients choose to tell their doctors? Qualitative analysis of potential barriers to reattributing medically unexplained symptoms. Journal of General Internal Medicine 2009;24(4):443-9.
127. Peveler R, Kilkenny L, Kinmonth AL. Medically unexplained physical symptoms in primary care: a comparison of self-report screening questionnaires and clinical opinion. Journal of Psychosomatic Research 1997;42(3):245-52.
128. Portegijs PJ, van der Horst FG, Proot IM, Kraan HF, Gunther NC, Knottnerus JA. Somatization in frequent attenders of general practice. Social Psychiatry and Psychiatric Epidemiology 1996;31(1):29-37.
129. Raine R, Haines A, Sensky T, Hutchings A, Larkin K, Black N. Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care?. BMJ 2002;325(7372):1082.
130. Rask MT, Olesen F, Bro F, Fink P, Rosendal M. Medically unexplained symptoms: consequences of diagnostic concepts in a primary care context. Scandinavian Journal of Primary Health Care 2013; Vol. under revision.
131. Robins L, Helzer J, Cottler L, Goldring E. NIMH Diagnostic Interview Schedule, Version III Revised (DIS-III-R). St Louis: Washington University, 1989.
132. Rosendal M, Fink P, Falko E, Hansen HS, Olesen F. Improving the classification of medically unexplained symptoms in primary care. European Journal of Psychiatry 2007;21(1):25-36.
133. Rosendal M, Vedsted P, Christensen KS, Moth G. Psychological and social problems in primary care patients - general practitioners' assessment and classification. Scandinavian Journal of Primary Health Care 2012;Submitted.
134. Salmon P, Humphris GM, Ring A, Davies JC, Dowrick CF. Primary care consultations about medically unexplained symptoms: patient presentations and doctor responses that influence the probability of somatic intervention. Psychosomatic Medicine 2007;69(6):571-7.
135. Salmon P, Peters S, Clifford R, Iredale W, Gask L, Rogers A, et al.Why do general practitioners decline training to improve management of medically unexplained symptoms?. Journal of General Internal Medicine 2007; Vol. 22:565-71.
136. Schroder A, Oernboel E, Licht RW, Sharpe M, Fink P. Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid. Journal of Clinical Epidemiology 2012; Vol. 65:30-41.
137. Schweickhardt A, Larisch A, Fritzsche K. Differentiation of somatizing patients in primary care: why the effects of treatment are always moderate. Journal of Nervous and Mental Diseases 2005;193(12):813-9.
138. Sharpe M, Mayou R, Walker J. Bodily symptoms: New approaches to classification. Journal of Psychosomatic Research 2006;60(4):353-6.
139. Smith GR Jr, Monson RA, Ray DC. Patients with multiple unexplained symptoms. Their characteristics, functional health, and health care utilization. Archives of Internal Medicine 1986;146(1):69-72.
140. Starfield B. Is primary care essential?. Lancet 1994;344(8930):1129-33.
141. Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics 2011;52(3):263-71.
142. Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosomatic Medicine 2007; Vol. 69:889-900.
143. Turner-Bowker DM, Bayliss MS, Ware JE Jr, Kosinski M. Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions. Quality of Life Research 2003;12(8):1003-12.
144. van der Feltz-Cornelis CM, van Oppen P, Ader HJ, van Dyck R. Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychotherapy and Psychosomatics 2006; Vol. 75:282-7.
145. van der Feltz-Cornelis CM, Swinkels JA, Blankenstein AH, Hoedeman R, Keuter EJ. [The Dutch multidisciplinary guideline entitled 'Medically unexplained physical symptoms and somatoform disorder] [De Nederlandse multidisciplinaire richtlijn 'Somatisch onvoldoende verklaarde lichamelijke klachten en somatoforme stoornissen]. Nederlands Tijdschrift voor Geneeskunde 2011;155(18):A1244.
146. Verhaak PF, Meijer SA, Visser AP, Wolters G. Persistent presentation of medically unexplained symptoms in general practice. Family Practice 2006;23(4):414-20.
147. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473-83.
148. Wearden AJ, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, Riste L, et al.Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial. BMJ 2010;340:c1777.
149. Weinman J, Petrie KJ, Moss-Morris R, Horne R. The illness perception questionnaire: a new method for assessing the cognitive representation of illness. Psychology & Health 1996;11:431-45.
150. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many?. Lancet 1999;354(9182):936-9.
151. Whitehead WE, Drossman DA. Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. American Journal of Gastroenterology 2010;105(4):814-20.
152. World Health Organization. Composite International diagnostic interview (CIDI). Geneva: World Health Organization, Division of Mental Health, 1990.
153. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: World Health Organization, 1993.
154. World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry (SCAN), version 2.1. Geneva: World Health Organization, Division of Mental Health, 1998.
155. World Health Organization. World Health Organization. Atlas - Mental Health Resources in the World 2001. Geneva: World Health Organisation, 2001.
156. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983;67(6):361-70.